Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Andlauer Healthcare Group Inc ANDHF


Primary Symbol: T.AND

Andlauer Healthcare Group Inc. is a Canada-based supply chain management company. The Company offers a robust platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector. Its 3PL services include customized logistics, distribution and packaging solutions for healthcare manufacturers across Canada. Its specialized transportation services in Canada, including air freight forwarding, ground transportation, dedicated delivery and last-mile services, provide a one-stop shop for clients' healthcare transportation needs. It operates in two segments: Specialized Transportation and Healthcare Logistics. Through its complementary service offerings, available across a coast-to-coast distribution network, it strives to accommodate the full range of its clients' specialized supply chain needs. The Company also provides specialized ground transportation services, primarily to the healthcare sector, across the 48 contiguous U.S. states.


TSX:AND - Post by User

Comment by hrgoyalon Nov 06, 2023 4:46pm
55 Views
Post# 35720214

RE:RE:TD with buy rating. Target price $51

RE:RE:TD with buy rating. Target price $51All 3 analysts have reduced the target price by $5. 
<< Previous
Bullboard Posts
Next >>